Partnervest Advisory Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Partnervest Advisory Services’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$262K	Buy	6,350 +500	+9%	+$21.6K	0.08%	189
2020 Q2	$284K	Hold	5,850	–	–	0.11%	152
2020 Q1	$247K	Hold	5,850	–	–	0.11%	155
2019 Q4	$250K	Sell	5,850 -200	-3%	-$8.7K	0.09%	172
2019 Q3	$218K	Buy	+6,050	New	+$183K	0.08%	204

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Partnervest Advisory Services's ACAD Position: Q3 2020 in Review

Partnervest Advisory Services increased its Acadia Pharmaceuticals (ACAD) stake by 8.5% in Q3 2020, buying an estimated $21.6K and bringing the position to 6,350 shares worth $262K. The position accounts for 0.08% of the portfolio, ranked #189.

Partnervest Advisory Services first reported a position in ACAD in Q3 2019 and has held it in 5 quarters since. The position peaked at $284K in Q2 2020. 267 funds tracked by Wall St. Rank hold ACAD as of Q3 2020.

Partnervest Advisory Services held 6,350 shares of Acadia Pharmaceuticals worth $262K as of Q3 2020.
Partnervest Advisory Services bought 500 Acadia Pharmaceuticals shares in Q3 2020, an estimated $21.6K.
Acadia Pharmaceuticals made up 0.08% of Partnervest Advisory Services's portfolio in Q3 2020, its #189 holding.
Partnervest Advisory Services first reported a position in Acadia Pharmaceuticals in Q3 2019 and has held it in 5 quarters since.
Partnervest Advisory Services's Acadia Pharmaceuticals position peaked at $284K in Q2 2020.
267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.